You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neurofibromatoses

Showing 26 - 50 of 202
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome Trial run by the National Cancer Institute (NCI) (Waitlist, ACT

Recruiting
  • Neurofibromatosis 1
  • +4 more
  • Waitlist
  • ACT Intervention
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Feb 2, 2023

Neurofibromatosis 1 Trial in Baltimore, Redwood City

Recruiting
  • Neurofibromatosis 1
    • Baltimore, California
    • +1 more
    Aug 17, 2022

    Cutaneous Neurofibroma Trial in New York (DPCP)

    Not yet recruiting
    • Cutaneous Neurofibroma
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 24, 2022

    Neurofibromatosis 1 Trial (curcumin, high phenolic extra virgin olive oil (HP-EVOO))

    Recruiting
    • Neurofibromatosis 1
    • curcumin, high phenolic extra virgin olive oil (HP-EVOO)
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Aug 23, 2022

    Validating Pain Scales in Children and Young Adults

    Recruiting
    • Sickle Cell Disease
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)

      Active, not recruiting
      • Neurofibromatosis 1
      • Neurofibroma Plexiform
      • Shanghai, China
      • +1 more
      Jan 13, 2023

      Neurofibromatoses, Neurofibromatosis 1, Neurofibromatosis 2 Trial in Boston (Stress and Symptom Management Program 1, Stress and

      Recruiting
      • Neurofibromatoses
      • +3 more
      • Stress and Symptom Management Program 1
      • Stress and Symptom Management Program 2
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 7, 2021

      Cutaneous Neurofibroma Trial in Copenhagen, Gothenburg (TOOsonix System ONE-M)

      Active, not recruiting
      • Cutaneous Neurofibroma
      • TOOsonix System ONE-M
      • Copenhagen, Hovedstaden, Denmark
      • +1 more
      Jun 23, 2022

      Neurofibromatosis, MPNST Trial run by the National Cancer Institute (NCI) (MRI, FDG-PET/CT scans, [18F]-FLT-PET/CT scans)

      Completed
      • Neurofibromatosis
      • MPNST
      • MRI, FDG-PET/CT scans
      • [18F]-FLT-PET/CT scans
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Neurofibromatosis Type 1 Trial in Los Angeles (Whole-body Magnetic Resonance Imaging)

      Recruiting
      • Neurofibromatosis Type 1
      • Whole-body Magnetic Resonance Imaging
      • Los Angeles, California
        Cedars Sinai Medical Center
      Jul 11, 2022

      Neurofibromatosis 1, Neurofibromatosis Type 1, NF1 Trial run by the National Cancer Institute (NCI) (AZD6244)

      Active, not recruiting
      • Neurofibromatosis 1
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Neurofibromatosis 1, Chronic Pain Trial in New Haven (iCanCope, iCanCope+Contingency Management)

      Completed
      • Neurofibromatosis 1
      • Chronic Pain
      • iCanCope
      • iCanCope+Contingency Management
      • New Haven, Connecticut
        Frank D Buono, PHD
      Sep 13, 2022

      Neurofibromatoses Trial in Boston (Stress and Symptom Management Program 1, Stress and Symptom Management Program 2)

      Recruiting
      • Neurofibromatoses
      • Stress and Symptom Management Program 1
      • Stress and Symptom Management Program 2
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 7, 2021

      Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

      Recruiting
      • Refractory Cancer
      • +14 more
      • Atlanta, Georgia
      • +1 more
      Oct 23, 2023

      Frameshift Peptides of Children With NF1

      Completed
      • Neurofibromatosis Type 1
      • Frameshift Array blood sample test
      • Washington, District of Columbia
      • +2 more
      Aug 29, 2022

      Neurofibroma, Neurofibroma, Plexiform Trial (Cryotherapy)

      Not yet recruiting
      • Neurofibroma
      • Neurofibroma, Plexiform
      • Cryotherapy
      • (no location specified)
      Jan 19, 2022

      Development of Non-Invasive Prenatal Diagnosis for Single Gene

      Not yet recruiting
      • Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including
      • +14 more
      • Blood sample
      • Paris, France
        Hôpital Cochin, Maternité Port-Royal, service de Gynécologie obs
      Nov 24, 2023

      Measures in Neurofibromatosis 1: Test- Retest

      Suspended
      • Neurofibromatosis Type 1
      • Outcome measures
      • London, United Kingdom
        Guy's Hospital
      Dec 23, 2021

      FARD (RaDiCo Cohort) (RaDiCo-FARD)

      Recruiting
      • Inherited Epidermolysis Bullosa
      • +8 more
        • Bobigny, France
        • +14 more
        Jul 18, 2023

        NEUROFIBROMATOSIS 1 Trial in Milwaukee (aminolevulinic acid)

        Recruiting
        • NEUROFIBROMATOSIS 1
        • aminolevulinic acid
        • Milwaukee, Wisconsin
          The Medical College of Wisconsin
        Nov 30, 2021

        Molecular Aspects of Preimplantation Genetic Diagnosis for NF1

        Recruiting
        • Neurofibromatosis Type 1
          • Strasbourg, France
            Service Laboratoire de Diagnostic Génétique - Hôpitaux Universit
          Nov 24, 2021

          Malignant Peripheral Nerve Sheath Tumor Development in

          Active, not recruiting
          • Neurofibromatosis 1
          • Peripheral Nerve Neoplasms, Malignant
            • Bethesda, Maryland
              National Cancer Institute (NCI)
            Jul 6, 2022

            Neurocognitive Deficit, Mental Health Impairment, Neurofibromatosis 1 Trial in Richmond (OPTIMAL-SSI)

            Recruiting
            • Neurocognitive Deficit
            • +2 more
            • OPTIMAL-SSI
            • Richmond, Virginia
              Children's Hospital of Richmond at Virginia Commonwealth Univers
            May 16, 2022

            Stem Cells in NF1 Tumors of the Central Nervous System

            Suspended
            • Neurofibromatosis Type 1
            • Tumors of the Central Nervous System
            • Collection of Stem Cells
            • Washington, District of Columbia
              Children's National Medical Center
            Mar 8, 2022

            Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

            Not yet recruiting
            • Hematologic Malignancy
            • +21 more
            • (no location specified)
            Feb 9, 2023